To test saliva and compare anti-caries agents for prevention of radiation caries among Head and Neck cancer patients undergoing radiotherapy.
Phase 1
- Conditions
- Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
- Registration Number
- CTRI/2019/03/017977
- Lead Sponsor
- itte Deemed to be University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosed with head and neck cancer.
- Patients undergoing radiotherapy with IMRT
-older than 12 years old age
Exclusion Criteria
- Patients not undergoing radiotherapy
-stage III and stage IV patients with trismus having restricted mouth opening
-patients undergoing surgery
-patients undergoing chemotherapy
-patients suffering from other systemic conditions
-Subjects those who have history of allergy to oil use
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method root caries index (RCI) for each subject will be calculatedTimepoint: To compare the changes in root caries index between the study groups at the 1st week, 6th ,12th and 24th week. (before and after radiotherapy)
- Secondary Outcome Measures
Name Time Method To compare the quantity and quality of saliva between the study groups using saliva kits.Timepoint: To compare the quantity and quality of saliva between the study groups at the 1st week, 6th ,12th and 24th week.